NCT00671658 2020-12-03
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
1 trialsCompleted × Precursor Cell Lymphoblastic Leukemia-Lymphoma × pegylated granulocyte colony-stimulating factor, human × Clear all